Sort
34,240 grants matching “atherosclerosis”
Acyl-CoAs and Lesion Initiation in Diabetes
$384,387Karin E. Bornfeldt · University Of Washington · R01 · FY2007 · HL
Role of Trimethylamine-N-oxide in endothelial dysfunction
$384,375Sai Sudha Koka · Texas A&M University Health Science Ctr · R01 · FY2024 · HL
Cholesterol Regulation of Endothelial K+ Channels
$384,341Irena Levitan · University Of Illinois At Chicago · R01 · FY2012 · HL
FRET Imaging of Molecular Hierarchy at Subcellular Levels in Mechanotransduction
$384,275Yingxiao Wang · University Of Illinois At Urbana-Champaign · R01 · FY2012 · HL
A novel CREBH-derived hepatokine regulates triglyceride metabolism
$384,272Kezhong Zhang · Wayne State University · R01 · FY2024 · DK
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics
$384,239M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2019 · GM
Chemical Biology of the Gut Microbiome: Target Discovery and Disease Therapeutics
$384,239M. Reza Ghadiri · Scripps Research Institute, The · R01 · FY2018 · GM
Regulation of PMCA Pump-Channels by Oxidant Stress
$384,236William P Schilling · Case Western Reserve University · R01 · FY2009 · HL
Vascular effects of dietary salt in humans with salt-resistant BP
$384,232William B Farquhar · University Of Delaware · R01 · FY2012 · HL
LIPOPROTEIN-RELATED CVD RISK FACTORS: QTL IDENTIFICATION
$384,204Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2011 · HL
Sleep and Cardiovascular Health
$384,198Phyllis C Zee · Northwestern University At Chicago · R01 · FY2012 · HL
Eicosapentaenoic acid activation of free fatty acid receptor 4 prevents fibrosis, microvascular rarefaction, and diastolic dysfunction; implications for heart failure preserved ejection fraction
$384,188Timothy Daniel O'Connell · University Of Minnesota · R01 · FY2016 · HL
LIPOPROTEIN-RELATED CVD RISK FACTORS: QTL IDENTIFICATION
$384,182Michael C. Mahaney · Texas Biomedical Research Institute · P01 · FY2012 · HL
Cadherins, integrins, and mechanochemical signaling
$384,172Christopher S Chen · University Of Pennsylvania · R01 · FY2008 · HL
Exercise and Vascular Function in Chronic Kidney Disease
$384,164David G Edwards · University Of Delaware · R01 · FY2015 · HL
Infammatory Proteases and Proteases and Diabetic Cardiomyopathy
$384,150Khadija Rafiq · Thomas Jefferson University · R01 · FY2015 · HL
Exploring the contribution of a nucleotide receptor to atherosclerosis
$384,150Cheikh Ibra Seye · Indiana University Indianapolis · R01 · FY2015 · HL
Tie Tek Modulation of Cardiac Development
$384,150H. Scott Baldwin · Vanderbilt University · R01 · FY2015 · HL
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation
$384,140William J Burlingham · Indiana University Indianapolis · P01 · FY2010 · AI
Smooth Muscle Cell Tissue Factor and Cardiovascular Disease
$384,062Mark B Taubman · University Of Rochester · R01 · FY2011 · HL
Flow Responsive Mediators of Inflammation and Survival
$384,062Bradford C Berk · University Of Rochester · R01 · FY2011 · HL
Specific Tissue Targeted Ultrasonic Contrast Agent
$384,057Barnes-Jewish Hospital · R01 · FY2001 · HL
Functional Analysis of ACAT
$384,025Ta-Yuan Chang · Dartmouth College · R01 · FY2009 · HL
Effects of miR-30c deficiency on plasma cholesterol and atherosclerosis
$384,000M Mahmood Hussain · Nyu Winthrop Hospital · R01 · FY2017 · HL
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS
$384,000Emory University · R01 · FY2003 · HL